San Diego Biotech’s ‘Molecular Glue’ Hits First Kidney Cancer Patient
San Diego biotech Neomorph has dosed the first patient in a Phase 1/2 trial of NEO‑811, a molecular glue for clear‑cell kidney cancer, after landing multibillion‑dollar pharma deals. Early safety and activity readouts will be the near‑term test.
University of Cincinnati Pioneers 'Brain Cancer-On-A-Chip' – Groundbreaking Wafer Technology to Weaponize Immune System Against Tumors
University of Cincinnati Cancer Center researchers aim to develop new glioblastoma treatments using "glioblastoma-on-a-chip" and immunostimulatory wafers following surgery.
Seattle Giant Amazon Stumbled On Huge Cache Of Child Sex Abuse Images In AI Data
Bloomberg reports Amazon flagged hundreds of thousands of suspected child-sex-abuse images in datasets used for AI training; child-safety groups say missing provenance makes many reports inactionable.
Fort Collins 11-Year-Old Skates Home After Ultra-Rare Heart-Liver Transplant
An 11-year-old from Fort Collins returned home after a rare combined heart-liver transplant at Children's Hospital Colorado. Surgeons and the family credited a speedy donor match and a coordinated, multidisciplinary team.
New York City Public Schools to Implement New AI Policy Amid Teacher Optimism and Parental Concerns
NYC public schools are establishing new rules for AI use, addressing concerns from parents and educators about privacy and the authenticity of students' work, with some schools creating their own AI policies in the interim.












